Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.00
Bid: 143.80
Ask: 144.60
Change: -1.20 (-0.83%)
Spread: 0.80 (0.556%)
Open: 149.80
High: 149.80
Low: 143.20
Prev. Close: 145.20
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM / Interim Management Statement

26 Apr 2012 07:00

RNS Number : 0942C
Elementis PLC
26 April 2012
 



 

26 April 2012

 

AGM / Interim Management Statement

 

Elementis plc (ELM.L, "the Company" or "the Group") today issues its Interim Management Statement for the three months ended 31 March 2012.

 

Commenting on the Company's performance Group Chief Executive, David Dutro, said: "Trading for the first three months of the year is ahead of the same period last year reflecting excellent progress in a number of key markets, which more than offset an anticipated general slowdown in Europe. The trend of robust margins, in combination with a solid order book, has continued and we expect full year earnings to be in line with market expectations."

 

In Specialty Products, sales in the first quarter were 7 per cent ahead of the same period last year as the business continued to benefit from its strategy of supplying high value products and technical service to a diversity of markets and high growth sectors.

 

·; Sales of coatings additives grew by 22 per cent in North America as the business benefited from improving customer demand and market share gains. Additives sales in Asia Pacific grew by 2 per cent, with improved margins. Sales in Europe were 8 per cent lower than the same period last year, reflecting the anticipated slowdown.

 

·; Sales to the oil and gas drilling sectors continue to show very strong growth, with sales up 42 per cent compared to the same period last year. Additives sales for both shale drilling and unconventional, high temperature, high pressure drilling continued to be the main contributors to the rapid growth and the business is investing in additional manufacturing capacity to support customer demand.

 

·; Sales in personal care were 3 per cent higher than the same period last year, reflecting further steady progress.

 

In Chromium, sales were 13 per cent higher than the same period last year. The increase in sales in the current period was partly the result of a planned plant closure in the early part of last year, in order to convert the US plant from heavy fuel oil to natural gas. Otherwise the business operated at high rates of capacity utilisation in both periods and, as such, we expect the rate of sales growth to be more modest across the remainder of the year. This key project was completed in April of last year and, together with a steady fall in US gas prices, resulted in energy costs being approximately $3 million lower in the first quarter of 2012 compared to the same period last year. The business has continued to optimise its flexible North American based operating model to generate stable earnings and cash flow. This flexibility ensured that the business has been able to replace softer European export sales with sales to more robust markets in North America. As a consequence sales to the domestic North American markets represented 65 per cent of Chromium sales, compared to 58 per cent in the same period last year.

 

The Group has an ongoing programme to invest in new products and manufacturing capacity to support growth in Specialty Products, and will continue to seek acquisitions that would enhance the geographic diversity and product offering of the business. In the meantime the Group continues to benefit from high levels of cash flow generation and a strong balance sheet, with a net cash position. The Board is in the process of reviewing the appropriate balance between cash reinvestment and shareholder returns and expects to provide an update on this at the time of the announcement of its Interim Results.

 

 

 

Enquiries:

Elementis + 44 (0) 207 408 9300

Brian Taylorson, Finance Director

  

FTI Consulting

 + 44 (0) 207 831 3113

Deborah Scott

Matthew Cole

  

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMGMGZDMKLGZZZ
Date   Source Headline
30th May 202412:52 pmRNSDirector/PDMR Shareholding
29th May 20241:07 pmRNSDirector Declaration
8th May 202411:08 amRNSDirector/PDMR Shareholding
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.